Synthes sale to J&J was driven to benefit its Chairman, Hansjoerg Wyss

By /

J&J’s Synthes deal purportedly benefited chairman (Bloomberg News) Johnson & Johnson’s $21.3 billion buyout of Synthes Inc. shortchanged the medical-device maker’s […]

Get access to full posts, newsletters, trends, and market reports for only subscribe for $1/day. 

Scroll to Top